US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 13.820
  • +0.020+0.14%
Close Mar 28 16:00 ET
  • 13.830
  • +0.010+0.07%
Post 20:01 ET
1.90BMarket Cap-2.68P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Arrowhead Pharmaceuticals Q1 2025 Earnings Date

Currency:USDFeb 10, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
19.05M
2.50M
-16.55M
Miss Est.
+436.47%
-29.60%
-86.88%
EPS
-0.38
-1.39
-1.01
Miss Est.
+69.26%
-12.10%
-264.64%
Buy

Mar 10, 2025

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 51.268M--
--2025/Q2-- / 116.268M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 51.268M--
--2025/Q2-- / 116.268M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

Read more

Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Mar 10, 2025

Buy

  • Buy

    63.64%
  • Hold

    36.36%
  • Sell

    0.00%

Price Target

No Data